Zacks Investment Research Upgrades Viking Therapeutics (NASDAQ:VKTX) to "Hold"

Retrieved on: 2021-02-23 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Upgrades Viking Therapeutics (NASDAQ:VKTX) to "Hold". View article details on hiswai:

Excerpt

BlackRock Inc. now owns 5,316,337 shares of the biotechnology company's stock valued at $29,931,000 after purchasing an additional 605,585 shares ...

Article found on: www.marketbeat.com